Search

Benzathine penicillin G (BPG) is used as first-line treatment for most forms of syphilis and as secondary prophylaxis against rheumatic heart disease (RHD). Perceptions that poor quality of BPG is linked to reported adverse effects and therapeutic failure may impact syphilis and RHD control programs. Clinical networks and web-based advertising were used to obtain vials of BPG from a wide range of countries.

This report provides an update on the contemporary global and regional policy landscapes relevant to rheumatic heart disease

Our findings are crucial in demonstrating that the Northern Territory STS clone is not STX resistant

The current prophylactic treatment to prevent rheumatic heart disease requires four-weekly intramuscular injection of a suspension of the poorly soluble benzathine salt form of penicillin G (BPG) often for more than 10 years. In seeking to reduce the frequency of administration to improve adherence, biodegradable polymer matrices have been investigated.

Barriers in addressing FASD in Australia include a drinking culture and large populations living in regional or remote communities with high risk populations.

Few studies have examined graphomotor skills in children with prenatal alcohol exposure (PAE) or fetal alcohol spectrum disorder (FASD)

There was evidence of extensive transmission of group A Streptococcus both within households and across the community

Given the ongoing mortality and morbidity from GAS infections, we must address more effectively the treatment and prevention of GAS impetigo and pharyngitis

We describe the development and evaluation of a protocol for digital image collection by the non-professional photographer in a remote setting research trial

This paper explains advances in extracting linked health data from the WA Data Linkage Branch